Yirui Biotech plunges over 10%, hitting a more than one-year low.

Gelonghui reported on April 27 that Yirui Biotech (300942.SZ) plunged by 10.84% during intraday trading to RMB 7.4, marking a new low for over a year since April 10 of the previous year. The company’s Q1 report for 2026 revealed that its revenue reached RMB 57.6441 million, representing a year-on-year increase of 16.82%; net profit attributable to shareholders was -RMB 10.2595 million; and non-recurring net profit attributable to shareholders stood at -RMB 13.2285 million. (Gelonghui)

Gelonghui FinanceApr 27 14:01

Yirui Biotechnology: 2025 Annual Report

SZSIApr 27 00:00 · Announcements

Yirui Biotechnology: First Quarter Report for 2026

SZSIApr 27 00:00 · Announcements

Yirui Biotechnology: Summary of the 2025 Annual Report

SZSIApr 27 00:00 · Announcements

Yirui Biotech (300942.SZ) reported a 19.71% year-on-year decline in net profit for 2025.

Gelonghui reported on April 26 that Yirui Bio-Tech (300942.SZ) released its 2025 annual report, showing the company achieved total revenue of 263 million yuan for the full year, representing a year-on-year increase of 17.38%. Net profit attributable to shareholders was 13.7433 million yuan, down 19.71% year-on-year, while non-recurring net profit attributable to shareholders was -9.6532 million yuan. The company proposed a cash dividend of 0.2468 yuan per 10 shares for all shareholders.

Gelonghui FinanceApr 26 17:52

Yirui Biotech (300942.SZ) reported a net loss of 10.2595 million yuan in the first quarter.

Gelonghui reported on April 26 that Yirui Bio-Tech (300942.SZ) released its Q1 2026 financial report, showing operating revenue of RMB 57.6441 million, a year-on-year increase of 16.82%; net profit attributable to shareholders of the parent company was -RMB 10.2595 million; and non-recurring net profit attributable to shareholders of the parent company was -RMB 13.2285 million.

Gelonghui FinanceApr 26 17:52